3.91

1.76% -0.07

Sight Sciences Inc (SGHT)

Overview News Price History Option Chain Financials Why SGHT Down? Discussions Forecast

Sight Sciences Inc stock is traded at $3.91, with a volume of 92,751. It is down -1.76% in the last 24 hours and down -24.81% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

Previous Close:

$3.98

Open:

$3.97

24h Volume:

92,751

Relative Volume:

0.47

Market Cap:

$203.10M

Revenue:

$81.06M

Net Income/Loss:

$-55.55M

P/E Ratio:

-2.6781

EPS:

-1.46

Net Cash Flow:

$-47.98M

1W Performance:

+4.83%

1M Performance:

-24.81%

6M Performance:

-29.80%

1Y Performance:

+16.72%

1-Day Range:

$3.90

$4.11

1-Week Range:

$3.72

$4.45

52-Week Range:

$2.58

$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name

Sight Sciences Inc

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

(415) 889-0550

Address

4040 CAMPBELL AVE,, MENLO PARK

Employee

214

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGHT Sight Sciences Inc	3.91	203.10M	81.06M	-55.55M	-47.98M	-1.46
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-04-24	Downgrade	Lake Street	Buy → Hold
Aug-21-24	Initiated	Lake Street	Buy
Sep-12-23	Downgrade	BofA Securities	Neutral → Underperform
Sep-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Sep-12-23	Downgrade	William Blair	Outperform → Mkt Perform
Aug-24-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jul-10-23	Downgrade	Citigroup	Buy → Neutral
Jan-06-23	Upgrade	Stifel	Hold → Buy
Oct-04-22	Initiated	Needham	Hold
Jul-26-22	Initiated	Stifel	Hold
Feb-03-22	Initiated	William Blair	Outperform
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Sight Sciences Inc Stock (SGHT) Latest News

Nov 26, 2024

Millrace Asset Group Inc. Acquires New Shares in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat

Nov 26, 2024

GSA Capital Partners LLP Invests $136,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Nov 26, 2024

Nov 24, 2024

Independent Chairman Of Sight Sciences Sold 25% Of Their Shares - Simply Wall St

Nov 24, 2024

Nov 22, 2024

Hedge Fund and Insider Trading News: Ken Griffin, Bridgewater Associates, AQR Capital Management, Brookfield Asset Management, Sight Sciences Inc (SGHT), Royal Caribbean Cruises Ltd (RCL), and More - Insider Monkey

Nov 22, 2024

Nov 21, 2024

Sight sciences EVP Manohar Raheja acquires $7,400 in stock By Investing.com - Investing.com Nigeria

Nov 21, 2024

Sight sciences EVP Manohar Raheja acquires $7,400 in stock - Investing.com

Nov 21, 2024

Sight Sciences director Encrantz sells $2.06 million in stock - Investing.com India

Nov 21, 2024

Nov 20, 2024

SGHTSight Sciences, Inc. Latest Stock News & Market Updates - StockTitan

Nov 20, 2024

Top 3 Health Care Stocks You'll Regret Missing In November - MSN

Nov 20, 2024

Nov 19, 2024

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 19, 2024

Sight Sciences to Present at Piper Sandler Healthcare Conference in December | SGHT Stock News - StockTitan

Nov 19, 2024

Nov 13, 2024

Sight Sciences, Inc. (NASDAQ:SGHT) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - Simply Wall St

Nov 13, 2024

Sight Sciences FY2024 EPS Estimate Raised by William Blair - MarketBeat

Nov 13, 2024

Sight Sciences Announces New Leadership Appointments - Vision Monday

Nov 13, 2024

Nov 12, 2024

Sight Sciences price target lowered to $5 from $7 at Morgan Stanley - Yahoo Finance

Nov 12, 2024